Pure Biologics S.A. (WSE:PUR)

Poland flag Poland · Delayed Price · Currency is PLN
9.10
+0.50 (5.81%)
May 12, 2025, 5:04 PM CET
25.52%
Market Cap 34.11M
Revenue (ttm) n/a
Net Income (ttm) -6.25M
Shares Out 3.75M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 54,413
Average Volume 38,575
Open 8.53
Previous Close 8.60
Day's Range 8.52 - 9.20
52-Week Range 6.35 - 33.20
Beta 1.59
RSI 38.15
Earnings Date Apr 16, 2025

About Pure Biologics

Pure Biologics S.A., a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified apta... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2010
Employees 51
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PUR
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.